Supplier
Carolina Blood and Cancer Care Associates, P.A.
Carolina Blood and Cancer Care Associates, P.A. was paid $652K by Medicaid between Jan 2018 and Nov 2024, across 33 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoCAROLINA BLOOD AND CANCER CARE ASSOCIATES, P.A.
ROCK HILL, SC 29732
ROCK HILL, SC 29732
33aNPI1013002013assigned 10/04/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$652K
24GClaims65,341
24DCodes billed33
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in South Carolina
Rank by total paid#46 of 160
Median peer was paid$125K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,111 | $89K | |
| 2019 | 9,373 | $75K | |
| 2020 | 8,314 | $72K | |
| 2021 | 10,712 | $100K | |
| 2022 | 11,231 | $128K | |
| 2023 | 7,020 | $113K | |
| 2024incomplete | 5,580 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 12,366 | 7,896 | $265K |
| 99490 | Ccm add 20min | 18% | 6,638 | 4,961 | $117K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.8% | 22,110 | 12,726 | $64K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.7% | 1,649 | 1,209 | $63K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8.7% | 920 | 485 | $57K |
| 99497 | 5.5% | 1,453 | 1,093 | $36K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.8% | 352 | 298 | $18K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 12,087 | 7,196 | $12K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 174 | 156 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 195 | 103 | $4K |
| 86328 | <1% | 64 | 58 | $3K | |
| 96367 | <1% | 112 | 52 | $2K |
21 more codes
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,348 | $2K |
| 96417 | <1% | 49 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 79 | $403.54 |
| 99406 | <1% | 81 | $402.96 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 234 | $260.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 228 | $194.08 |
| 80053 | Comprehensive metabolic panel | <1% | 15 | $123.42 |
| 99072 | <1% | 489 | $26.78 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 25 | $22.81 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 40 | $22.24 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 2,410 | $0.52 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 690 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 323 | $0.00 |
| 1124F | 0% | 137 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 63 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 27 | $0.00 |
| 4040F | 0% | 25 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 26 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 596 | $0.00 |
| 1036F | 0% | 322 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWELSH, JAMES (CEO)